研究
2018 研究業績・論文発表
論文
Hitomi Sakai, Junji Tsurutani, Tsutomu Iwasa, Yoshifumi Komoike, Kazuko Sakai, Kazuto Nishio, Kazuhiko Nakagawa
HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer
Breast Cancer. 2018; 25(5): 605–613.
JUN YAMAMURA, SHUNJI KAMIGAKI, JUNYA FUJITA, HIROKI OSATO, YOSHIFUMI KOMOIKE
The Difference in Prognostic Outcomes Between De Novo Stage IV and Recurrent Metastatic Patients with Hormone Receptor-positive, HER2-negative Breast Cancer
In Vivo. 2018 Mar-Apr; 32(2): 353–358.